TROW
42
-5
AAPL
45
-3
HUM
37
3
CA
13
6
ECL
60
-2
TDC
62
-8
ABT
56
2
PCAR
50
-6
WAT
31
-2
OKE
62
-2
BK
71
-3
EA
52
2
RHI
55
-2
XRX
24
-3
BF.B
33
-6
CINF
47
12
ZTS
34
-2
OI
28
-6
DE
42
-4
ALLE
41
-3
TROW
42
-5
AAPL
45
-3
HUM
37
3
CA
13
6
ECL
60
-2
TDC
62
-8
ABT
56
2
PCAR
50
-6
WAT
31
-2
OKE
62
-2
BK
71
-3
EA
52
2
RHI
55
-2
XRX
24
-3
BF.B
33
-6
CINF
47
12
ZTS
34
-2
OI
28
-6
DE
42
-4
ALLE
41
-3
Financhill
Back

NKGen Biotech 10K Form

Sell
6

NKGN
NKGen Biotech

Last Price:
0.28
Seasonality Move:
-3.87%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NKGN News And Ratings

See the #1 stock for the next 7 days that we like better than NKGN

NKGN Financial Statistics

Sales & Book Value

Annual Sales: $77K
Cash Flow: $-6.01M
Price / Cash Flow: 0
Annual Sales: $-2.71
Price / Book: 0

Profitability

EPS (TTM): -5.08000
Net Income (TTM): $-88.25M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

NKGen Biotech Earnings Forecast

Key NKGen Biotech Financial Ratios

  • The Selling, General & Administrative Expenses for NKGN have been equal to 9,946.75% of Gross Profit Margin.
  • The Interest Expense is -0.90% of Operating Income.
  • Per Share Earnings over the last 3 years have been positive in 0 years.

NKGen Biotech Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: NKGN
Website: nkgenbiotech.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

NKGN Technical Analysis vs Fundamental Analysis

Sell
6
NKGen Biotech (NKGN) is a Sell

Is NKGen Biotech a Buy or a Sell?

  • NKGen Biotech stock is rated a Sell
    The current NKGen Biotech [NKGN] share price is $0.29. The Score for NKGN is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.